At the time of writing, eHealth Inc [EHTH] stock is trading at $7.70, up 41.03%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EHTH shares have gain 40.00% over the last week, with a monthly amount glided 61.09%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
eHealth Inc [NASDAQ: EHTH] stock has seen the most recent analyst activity on December 04, 2024, when UBS initiated its Neutral rating and assigned the stock a price target of $5.50. Previously, Craig Hallum downgraded its rating to Hold on January 18, 2024, and kept the price target unchanged to $7. On December 01, 2022, upgrade upgraded it’s rating to Buy but maintained its price target of $6 on the stock. Citigroup downgraded its rating to a Neutral and reduced its price target to $15 on March 21, 2022. Truist downgraded its rating to Hold for this stock on March 02, 2022. In a note dated March 02, 2022, Evercore ISI downgraded an In-line rating on this stock.
For the past year, the stock price of eHealth Inc fluctuated between $3.58 and $9.45. Currently, Wall Street analysts expect the stock to reach $4.5 within the next 12 months. eHealth Inc [NASDAQ: EHTH] shares were valued at $7.70 at the most recent close of the market. An investor can expect a potential drop of -41.56% based on the average EHTH price forecast.
Analyzing the EHTH fundamentals
According to eHealth Inc [NASDAQ:EHTH], the company’s sales were 464.89M for trailing twelve months, which represents an -9.75% plunge. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.1%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.05 and Total Capital is -0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.93 points at the first support level, and at 6.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.28, and for the 2nd resistance point, it is at 8.87.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 0.49, the price to book ratio is 0.46.
Transactions by insiders
Recent insider trading involved WOLF DALE B, Director, that happened on Nov 11 ’24 when 16403.0 shares were sold. Director, WOLF DALE B completed a deal on Nov 08 ’24 to sell 3597.0 shares. Meanwhile, Director WOLF DALE B bought 20000.0 shares on Nov 08 ’24.
